Trial Profile
Effect of Ivabradine on Residual angina after Percutaneous coronary intervention in patients without Left-ventricular systolic dysfunction
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2018
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary)
- Indications Angina pectoris
- Focus Therapeutic Use
- 11 Dec 2018 New trial record
- 14 Nov 2018 Results presented at the 91st Annual Scientific Sessions of the American Heart Association